Nadroparin Calcium is a low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot. It is grouped under the following drug class(es): Antithrombotic agents. Its therapeutic use is listed as anticoagulants and hematologic agents. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Fraxiparin, Fraxiparina, Seleparina and Ultraparina. Its PubChem SID is 481109256.
Nadroparin calcium
| CAS No | 37270-89-6 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | ~4.3 kDa |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nadroparin Calcium is a low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt.
The listed CAS number is 37270-89-6.
The listed molecular formula is N/A.
The listed molecular weight is ~4.3 kDa.
N/A.
The source lists Fraxiparin, Fraxiparina, Seleparina and Ultraparina.